Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
M.D. Anderson Cancer Center
Day One Biopharmaceuticals, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)